Exagen (XGN) Non-Current Assets (2018 - 2026)

Exagen has reported Non-Current Assets for 9 years, with the latest figure at $8.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 7.51% year-over-year to $8.4 million; the trailing twelve-month figure through Mar 2026 stood at $35.5 million (up 8.98% YoY), and the FY2025 full-year result was $9.1 million, up 10.87% from the prior year.
• Non-Current Assets for Q1 2026 stood at $8.4 million, down from $9.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $19.5 million in Q3 2022, with the low at $7.8 million in Q2 2025.
• Historically, Non-Current Assets has averaged $11.4 million across 5 years, with a median of $9.1 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Assets jumped 125.78% — and 2023, when it plunged 38.48%.
• Exagen's Non-Current Assets stood at $13.6 million in 2022, then tumbled by 33.12% to $9.1 million in 2023, then slipped by 9.55% to $8.2 million in 2024, then gained by 10.87% to $9.1 million in 2025, then declined by 8.27% to $8.4 million in 2026.
• The last three Non-Current Assets figures came in at $8.4 million (Q1 2026), $9.1 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.